Cargando…

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na(+)/I(−) Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells

Previously, we reported that an inverse agonist of estrogen-related receptor gamma (ERRγ), GSK5182, enhances sodium iodide (Na(+)/I(−)) symporter (NIS) function through mitogen-activated protein (MAP) kinase signaling in anaplastic thyroid cancer cells. This finding helped us to further investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Thoudam Debraj, Lee, Jae Eon, Son, Kwang Hee, Lee, Bo Ra, Kim, Sang Kyoon, Gulwani, Deepak, Sarangthem, Vijaya, Jeon, Yong Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914548/ https://www.ncbi.nlm.nih.gov/pubmed/36766812 http://dx.doi.org/10.3390/cells12030470

Ejemplares similares

Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane
por: Gulwani, Deepak, et al.
Publicado: (2023)

An Inverse Agonist GSK5182 Increases Protein Stability of the Orphan Nuclear Receptor ERRγ via Inhibition of Ubiquitination
por: Na, Soon-Young, et al.
Publicado: (2022)

The estrogen-related receptor γ modulator, GSK5182, inhibits osteoclast differentiation and accelerates osteoclast apoptosis
por: Kim, Hyun-Ju, et al.
Publicado: (2021)

GSK5182, 4-Hydroxytamoxifen Analog, a New Potential Therapeutic Drug for Osteoarthritis
por: Min, Yunhui, et al.
Publicado: (2020)

Effects of molecular weight and structural conformation of multivalent-based elastin-like polypeptides on tumor accumulation and tissue biodistribution
por: Sarangthem, Vijaya, et al.
Publicado: (2020)

The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAF(V600E) Mutation
por: Anekpuritanang, Tauangtham, et al.
Publicado: (2021)

Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
por: Lee, Jin Hee, et al.
Publicado: (2022)

Therapeutic Effect of IL-4 Receptor-Targeting Pro-Apoptotic Peptide (AP1-ELP-KLAK) in Glioblastoma Tumor Model
por: Sarangthem, Vijaya, et al.
Publicado: (2021)

Multivalent Targeting Based Delivery of Therapeutic Peptide using AP1-ELP Carrier for Effective Cancer Therapy
por: Sarangthem, Vijaya, et al.
Publicado: (2016)

Application of Bio-Active Elastin-like Polypeptide on Regulation of Human Mesenchymal Stem Cell Behavior
por: Sarangthem, Vijaya, et al.
Publicado: (2022)

Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake
por: Chung, Taemoon, et al.
Publicado: (2015)

Dissimilar Friction Stir Welding of AA2519 and AA5182
por: Zuiko, Ivan S., et al.
Publicado: (2022)

Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter
por: Huang, R, et al.
Publicado: (2011)

Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells
por: Liu, Zhi, et al.
Publicado: (2012)

Enhancement of Natural Killer Cell Cytotoxicity by Sodium/Iodide Symporter Gene-Mediated Radioiodine Pretreatment in Breast Cancer Cells
por: Kim, Hae Won, et al.
Publicado: (2013)

Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes
por: Lee, Ho Won, et al.
Publicado: (2015)

Construction and Application of Elastin Like Polypeptide Containing IL-4 Receptor Targeting Peptide
por: Sarangthem, Vijaya, et al.
Publicado: (2013)

Effects of Sc and Zr Addition on Microstructure and Mechanical Properties of AA5182
por: Li, Jingxiao, et al.
Publicado: (2021)

Corrigendum: Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes
por: Won Lee, Ho, et al.
Publicado: (2015)

The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma
por: LI, WEI, et al.
Publicado: (2013)

A Steep Radioiodine Dose Response Scalable to Humans in Sodium Iodide Symporter (NIS) Mediated Radiovirotherapy for Prostate Cancer
por: Trujillo, Miguel A., et al.
Publicado: (2012)

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
por: Hutzen, Brian, et al.
Publicado: (2012)

Effects of Ce-Rich Mischmetal on Microstructure Evolution and Mechanical Properties of 5182 Aluminum Alloy
por: Gong, Tianhao, et al.
Publicado: (2019)

Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer
por: Plantinga, Theo S., et al.
Publicado: (2016)

Determining Homogenization Parameters and Predicting 5182-Sc-Zr Alloy Properties by Artificial Neural Networks
por: Li, Jingxiao, et al.
Publicado: (2023)

Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
por: Zhang, Honglai, et al.
Publicado: (2018)

Primary Papillary Mucinous Adenocarcinoma of the Ureter Mimicking Genitourinary Tuberculosis
por: Gulwani, Hanni, et al.
Publicado: (2010)

Method of Stamping the Progression of a Beverage End Rivet of a Thinner Sheet of AW-5182 Alloy
por: Łucarz, Mariusz, et al.
Publicado: (2023)

Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer
por: Lee, Fang, et al.
Publicado: (2022)

Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression
por: Na, Juri, et al.
Publicado: (2023)

Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?
por: Krčálová, Eva, et al.
Publicado: (2016)

Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter
por: Gao, Xiao-Feng, et al.
Publicado: (2014)

Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells
por: Chatterjee, Sushmita, et al.
Publicado: (2015)

Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells
por: Xu, Shichen, et al.
Publicado: (2021)

Proteomic analysis of radioiodine-refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium-iodine symporter
por: Li, Yunjie, et al.
Publicado: (2022)

Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene
por: Oh, Seul-Gi, et al.
Publicado: (2023)

Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model
por: Ahn, S J, et al.
Publicado: (2010)

Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha
por: Karnati, Konda Reddy, et al.
Publicado: (2020)

Application of Bld-1-Embedded Elastin-Like Polypeptides in Tumor Targeting
por: Sarangthem, Vijaya, et al.
Publicado: (2018)

Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
por: van Velsen, Evert F S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d0qkfad39bu9es94qma2d35d02